Diaceutics Plc (DXRX) Ord GBP0.002
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Diaceutics appoints new VP of marketing
9 April 2024 12:34
(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.
-
Director dealings: BAT, Diaceutics execs make investments
6 June 2023 13:47
(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.
-
Diaceutics shares resume trading after HSBC buys SVB UK
13 March 2023 11:10
(Sharecast News) - Pharmaceutical technology and service provider Diaceutics announced at mid-morning on Monday that the temporary suspension of its shares on AIM would be lifted.
-
Diaceutics secures $2m multi-year contract with global pharma company
13 June 2022 10:30
(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceutical company to deliver customised data insights...
-
Diaceutics inks five-year deal with existing pharma partner
5 May 2022 12:58
(Sharecast News) - Diaceutics announced a five-year, multi-product subscription contract with an unnamed "top 30" global pharma company on Thursday, to deliver customised data insights via its...
-
Diaceutics secures $1m subscription contract with 'leading life sciences company'
14 December 2021 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Tuesday that it had secured a $1.0m contract with a "leading life sciences company" to provide data feed from its DXRX...
-
Diaceutics delivers 'strong start' to 2021 despite ongoing pandemic
8 July 2021 09:56
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Thursday that it had delivered "a strong start to the 2021 financial year", in line with management's expectations...
-
Diaceutics secures multiple contracts with 'leading' pharma firms
24 June 2021 10:15
(Sharecast News) - Diagnostics commercialisation company Diaceutics has secured four contracts with two "leading pharmaceutical companies" to solve real-world testing hurdles for inherited retinal...
Company announcements Announcements
-
Appointment of Amie Mc Neice as VP of Marketing
9 April 2024 07:00
Diaceutics
-
Block Listing Return
5 April 2024 13:40
Diaceutics
-
PDMR Shareholding/Share Incentive Plan
3 April 2024 07:00
Diaceutics
-
Director/PDMR/PCA Shareholding & TR1
2 April 2024 07:00
Diaceutics
-
Director/PDMR Shareholding
7 March 2024 07:00
Diaceutics
-
PDMR Shareholding / SIP and TVR
1 March 2024 09:00
Diaceutics
-
Expanded lab network and data capabilities
27 February 2024 07:00
Diaceutics
-
Diaceutics PLC - Strategic alliance with KPMG
14 February 2024 13:00
Diaceutics
-
PDMR Shareholding/Share Incentive Plan and TVR
1 February 2024 12:31
Diaceutics
-
Diaceutics PLC – Trading Update
30 January 2024 07:00
Diaceutics
-
Exercise of Warrant & Total Voting Rights
25 January 2024 13:16
Diaceutics
-
Diaceutics PLC – Financial Calendar Update
19 January 2024 07:00
Diaceutics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.